313 related articles for article (PubMed ID: 35338074)
21. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease.
Mueller KD; Koscik RL; Du L; Bruno D; Jonaitis EM; Koscik AZ; Christian BT; Betthauser TJ; Chin NA; Hermann BP; Johnson SC
Cortex; 2020 Oct; 131():137-150. PubMed ID: 32861209
[TBL] [Abstract][Full Text] [Related]
22. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.
Ismail R; Parbo P; Madsen LS; Hansen AK; Hansen KV; Schaldemose JL; Kjeldsen PL; Stokholm MG; Gottrup H; Eskildsen SF; Brooks DJ
J Neuroinflammation; 2020 May; 17(1):151. PubMed ID: 32375809
[TBL] [Abstract][Full Text] [Related]
23. Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
Grober E; Lipton RB; Sperling RA; Papp KV; Johnson KA; Rentz DM; Veroff AE; Aisen PS; Ezzati A
Neurology; 2022 Mar; 98(13):e1327-e1336. PubMed ID: 35197359
[TBL] [Abstract][Full Text] [Related]
24. Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.
Prokopiou PC; Engels-Domínguez N; Schultz AP; Sepulcre J; Koops EA; Papp KV; Marshall GA; Normandin MD; El Fakhri G; Rentz D; Sperling RA; Johnson KA; Jacobs HIL
Neurology; 2023 Sep; 101(12):e1206-e1217. PubMed ID: 37491329
[TBL] [Abstract][Full Text] [Related]
25. Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition.
Tideman P; Stomrud E; Leuzy A; Mattsson-Carlgren N; Palmqvist S; Hansson O;
Neurology; 2022 Apr; 98(15):e1525-e1533. PubMed ID: 35022305
[TBL] [Abstract][Full Text] [Related]
26. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease.
Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O
Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656
[TBL] [Abstract][Full Text] [Related]
27. Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
Gonzalez C; Mimmack KJ; Amariglio RE; Becker JA; Chhatwal JP; Fitzpatrick CD; Gatchel JR; Johnson KA; Katz ZS; Kuppe MK; Locascio JJ; Udeogu OJ; Papp KV; Premnath P; Properzi MJ; Rentz DM; Schultz AP; Sperling RA; Vannini P; Wang S; Marshall GA
J Alzheimers Dis; 2023; 94(1):217-226. PubMed ID: 37212093
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults.
Aslanyan V; Ortega N; Fenton L; Harrison TM; Raman R; Mack WJ; Pa J
Neuroimage Clin; 2023; 39():103460. PubMed ID: 37379733
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
30. Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.
Huijbers W; Schultz AP; Papp KV; LaPoint MR; Hanseeuw B; Chhatwal JP; Hedden T; Johnson KA; Sperling RA
J Neurosci; 2019 Jan; 39(3):548-556. PubMed ID: 30482786
[TBL] [Abstract][Full Text] [Related]
31. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
[TBL] [Abstract][Full Text] [Related]
32. Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.
Buckley RF; Scott MR; Jacobs HIL; Schultz AP; Properzi MJ; Amariglio RE; Hohman TJ; Mayblyum DV; Rubinstein ZB; Manning L; Hanseeuw BJ; Mormino EC; Rentz DM; Johnson KA; Sperling RA
Ann Neurol; 2020 Nov; 88(5):921-932. PubMed ID: 32799367
[TBL] [Abstract][Full Text] [Related]
33. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease.
Cai Y; Du J; Li A; Zhu Y; Xu L; Sun K; Ma S; Guo T;
Alzheimers Res Ther; 2023 Feb; 15(1):30. PubMed ID: 36750884
[TBL] [Abstract][Full Text] [Related]
34. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.
Papp KV; Amariglio RE; Mormino EC; Hedden T; Dekhytar M; Johnson KA; Sperling RA; Rentz DM
Neuropsychologia; 2015 Jul; 73():169-75. PubMed ID: 26002757
[TBL] [Abstract][Full Text] [Related]
35. Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
Tian Q; Bilgel M; Moghekar AR; Ferrucci L; Resnick SM
J Alzheimers Dis; 2022; 86(3):1275-1285. PubMed ID: 35180111
[TBL] [Abstract][Full Text] [Related]
36. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
37. Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
Yang HS; Yau WW; Carlyle BC; Trombetta BA; Zhang C; Shirzadi Z; Schultz AP; Pruzin JJ; Fitzpatrick CD; Kirn DR; Rabin JS; Buckley RF; Hohman TJ; Rentz DM; Tanzi RE; Johnson KA; Sperling RA; Arnold SE; Chhatwal JP
Brain; 2024 Jun; 147(6):2158-2168. PubMed ID: 38315899
[TBL] [Abstract][Full Text] [Related]
38. Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline.
Yau WW; Shirzadi Z; Yang HS; Ikoba AP; Rabin JS; Properzi MJ; Kirn DR; Schultz AP; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
Ann Neurol; 2022 Nov; 92(5):745-755. PubMed ID: 35880989
[TBL] [Abstract][Full Text] [Related]
39. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
40. Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.
Soldan A; Pettigrew C; Cai Q; Wang MC; Moghekar AR; O'Brien RJ; Selnes OA; Albert MS;
JAMA Neurol; 2016 Jun; 73(6):698-705. PubMed ID: 27064267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]